64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for …

RJ Hicks, P Jackson, G Kong, RE Ware… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

64Cu-sartaTE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for …

RJ Hicks, P Jackson, G Kong, RE Ware… - Journal of Nuclear …, 2019 - research.monash.edu
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

[PDF][PDF] 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective …

RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman… - J Nucl …, 2019 - Soc Nuclear Med
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry …

RJ Hicks, P Jackson, G Kong… - Journal of nuclear …, 2019 - pubmed.ncbi.nlm.nih.gov
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

[引用][C] 64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry …

RJ Hicks, P Jackson, G Kong… - Journal of Nuclear …, 2018 - espace.library.uq.edu.au
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

[HTML][HTML] 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective …

RJ Hicks, P Jackson, G Kong, RE Ware… - Journal of Nuclear …, 2019 - ncbi.nlm.nih.gov
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

[PDF][PDF] 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective …

RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman… - J Nucl Med, 2019 - academia.edu
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry …

RJ Hicks, P Jackson, G Kong, RE Ware… - Journal of Nuclear …, 2018 - europepmc.org
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

Cu-64-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry …

RJ Hicks, P Jackson, G Kong… - Journal of …, 2019 - research-repository.uwa.edu.au
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …

[PDF][PDF] 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective …

RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman… - J Nucl Med, 2019 - academia.edu
Imaging of somatostatin receptor expression is an established technique for staging of
neuroendocrine neoplasia and determining the suitability of patients for peptide receptor …